Listing ID #4202723
Company Information
Ask for more detail from the seller
Contact SupplierCAPRELSA (vandetanib) is a kinase inhibitor used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. CAPRELSA can also be used to treat a patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA. It is approved by the Food and Drug Administration (FDA).
SIDE EFFECTS
Most Common side effects may be Diarrhea, Rash, Elevated Liver Enzymes (ALT), Low calcium levels, Acne, High blood pressure, Nausea, Headache, Fatigue, Low blood sugar, Abdominal pain, Poor appetite, Low white blood cell count, Kidney problems, Dry skin, Vomiting, Weakness, Irregular, heart beat, Insomnia (difficulty sleeping), Photosensitivity (sensitivity to sunlight), Bleeding, Anemia, Liver tests increased (bilirubin), Itching, Heartburn, Cough, Upper respiratory infection, Depression, Weight loss.